Bacolot, Irene .

HRN: 24-93-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2025
CEFTRIAXONE 1G (VIAL)
04/29/2025
05/06/2025
IV
2g
OD
UTI
Waiting Final Action 
05/02/2025
CEFUROXIME 500MG (TAB)
05/02/2025
05/08/2025
PO
500mg
BID
Severe UTI
Waiting Final Action 
05/24/2025
CEFTRIAXONE 1G (VIAL)
05/24/2025
05/30/2025
IV
2g
Od
Uti
Checking Initial Appropriateness 
05/25/2025
AZITHROMYCIN 500MG TABLET (TAB)
05/25/2025
05/29/2025
PO
500mg
OD
CAPMR
Waiting Final Action 
05/27/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/27/2025
06/17/2025
IV
4.5g
Q6
UROSEPSIS
Remove - Pending Acceptance
05/31/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/31/2025
06/21/2025
IV
500mg
Q24H
Complicated UTI
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: